Product Details
| Cat.No. | EDC07559 | Product Name | FOXN3 Knockout HEPG2 Cell Line |
|---|---|---|---|
| Species | Human | Cell Line | Hep-G2 |
| Cellosaurus ID | CVCL_0027 | Cell Line Synonyms | HEP-G2, Hep G2, HEP G2, HepG2, HEPG2 |
| NCBI Gene ID | Gene | ||
| Summary |
This gene is a member of the forkhead/winged helix transcription factor family. Checkpoints are eukaryotic DNA damage-inducible cell cycle arrests at G1 and G2. Checkpoint suppressor 1 suppresses multiple yeast checkpoint mutations including mec1, rad9, rad53 and dun1 by activating a MEC1-independent checkpoint pathway. Alternative splicing is observed at the locus, resulting in distinct isoforms. [provided by RefSeq, Jul 2008]
|
Associated Diseases | Hepatocellular Carcinoma |
| Digestion Time | 1.5 min~2 min | Morphology | Adherent |
| Passage Ratio | 1:3,3 days | Complete Culture Medium | DMEM+10% FBS |
| Freezing Medium | 50% basic culture medium+40% FBS+10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
STR Profile
| Loci | STR Info (Sample Cell) Sample Cell Line: Hep-G2 | STR Info (Cell bank) Cell Line: Hep-G2 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | Y | X | Y |
| CSF1P0 | 10 | 11 | 10 | 11 |
| D2S1338 | 19 | 20 | 19 | 20 |
| D3S1358 | 15 | 16 | 15 | 16 |
| D5S818 | 11 | 12 | 11 | 12 |
| D7S820 | 10 | 10 | ||
| D8S1179 | 15 | 16 | 15 | 16 |
| D13S317 | 9 | 13 | 9 | 13 |
| D16S539 | 12 | 12 | 13 | |
| D18S51 | 13 | 14 | 13 | 14 |
| D19S433 | 15.2 | 15.2 | ||
| D21S11 | 29 | 31 | 29 | 31 |
| FGA | 22 | 25 | 22 | 25 |
| Penta D | 9 | 13 | 9 | 13 |
| Penta E | 15 | 20 | 15 | 20 |
| TH01 | 9 | 9 | ||
| TPOX | 8 | 9 | 8 | 9 |
| vWA | 17 | 17 | ||
| D6S1043 | 13 | |||
| D12S391 | 21 | 25 | 21 | 25 |
| D2S441 | 11.3 | 14 | 11.3 | 14 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying FOXN3 function, FOXN3 Knockout Hep-G2 Cell Line or FOXN3 overexpression Hep-G2 Cell Line?
The choice depends on whether you are studying FOXN3 (forkhead box N3, CHES1)'s role as a checkpoint suppressor or its emerging functions in glucose metabolism and hepatic biology. The Knockout line is the standard tool for asking whether FOXN3 is required for these processes — FOXN3 is a forkhead transcription factor originally identified as a checkpoint suppressor in S. cerevisiae complementation; FOXN3 has emerged as a regulator of hepatic glucose production with FOXN3 polymorphisms associated with fasting glucose in human GWAS. Overexpression is useful for studying FOXN3 in heterologous expression contexts.
For hepatic metabolism research, the EDITGENE FOXN3 Knockout in Hep-G2 is highly relevant — Hep-G2 is a hepatocellular carcinoma cell line and FOXN3 has been characterized as a regulator of hepatic glucose production. This product complements the parallel FOXN3 Knockout in A-549 (also available) for hepatic versus lung cancer cross-validation. Rescue with wild-type FOXN3 is the standard specificity control. The knockout is valuable for studying FOXN3-dependent hepatic gene regulation, fasting glucose biology, and emerging FOXN3-related metabolic disease research.
Is this FOXN3 Knockout Hep-G2 Cell Line compatible with overexpression rescue experiments?
Yes. FOXN3 rescue experiments require attention to forkhead transcription factor architecture:
• Construct design: use a codon-modified FOXN3 sequence with a small C-terminal tag (FLAG, HA). FOXN3 has central forkhead DNA-binding domain and N/C-terminal regulatory regions — preserve all elements.
• DNA-binding-deficient rescue: forkhead domain mutations abolish DNA binding and serve as the standard specificity control.
• Functional readout: rescue should restore FOXN3-dependent transcriptional programs in hepatocellular context.
Hep-G2-specific considerations:
• Hep-G2 is a human hepatocellular carcinoma cell line widely used for hepatocyte differentiation, drug metabolism, and liver biology research.
• Lentiviral transduction is supported with moderate efficiency.
• Hep-G2 retains many hepatocyte features (albumin synthesis, CYP450 expression, transferrin synthesis) and serves as a complementary HCC model to Huh-7.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.